Martha Carnalla1, Ana Basto-Abreu2, Dalia Stern3
1Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública. Cuernavaca, Morelos, México.. mcarnalla@gmail.com.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
High SARS-CoV-2 antibody prevalence in Mexico, driven by infection and vaccination, was observed. Addressing specific age and regional barriers is crucial for future vaccination efforts.
Area of Science:
Context:
Purpose:
Summary:
Impact: